Home
Conditions
Leukemia, Myeloid, Chronic-Phase

Clinical trial condition

Leukemia, Myeloid, Chronic-Phase

Explore clinical trials studying Leukemia, Myeloid, Chronic-Phase. Study availability and eligibility vary by location and protocol.

314 public trials 19 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Myeloid, Chronic-Phase trial results

Completed

Nilotinib 300 mg BID in Newly Diagnosed CP-CML Patients to Verify Disappearance of CD34+/Lin-Ph+ Cells

NCT01856283

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations: A.O. Ospedale S. Antonio Gallarate, Milano, Italy

Ospedale Desio- "Ospedale Civile" di Vimercate, Desio, Carate Brianza, Giussano, Seregno. Vimercate, Milano, Italy

A.O di Circolo di Busto Arsizio Busto Arsizio, Varese, Italy

Ospedali Riuniti Bergamo Bergamo, Italy

View all 17 locations

View Trial Details

Completed

Ruxolitinib in Combination With Nilotinib in Chronic Myeloid Leukemia (CML) Patients

NCT01702064

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Phase Chronic Myeloid Leukemia, +12 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

Bone Marrow Transplant in Treating Patients With Hematologic Cancers

NCT00005797

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +52 more
Locations: H. Lee Moffitt Cancer Center and Research Institute at University of South Florida Tampa, Florida, United States

View Trial Details

Completed

Phase I/II Study of Nilotinib/Ruxolitinb Therapy for TKI Resistant Ph-Leukemia

NCT01914484

Conditions: Accelerated Phase Chronic Myeloid Leukemia, Blast Crisis, Blastic Phase Chronic Myeloid Leukemia, +27 more
Locations: Princess Margaret Hospital / University Health Network Toronto, Ontario, Canada

View Trial Details

Completed

Vaccine Therapy and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia

NCT00301093

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell Transplant

NCT00534118

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +58 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter

NCT00006083

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +94 more
Locations: Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States

View Trial Details

Completed

Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

NCT00079222

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +109 more
Locations: Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States

View Trial Details

Completed

BMS-354825 in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Is Resistant to Imatinib Mesylate

NCT00064233

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations: Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States

View Trial Details

Completed

Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies

NCT00068523

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +68 more
Locations: Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Leukemia, Myeloid, Chronic-Phase

Leukemia, Myeloid, Chronic-Phase trial results

Related conditions